Droxidopa May Reduce Neurogenic Orthostatic Hypotension Symptoms in Patients Taking DDCIsAugust 1, 2018Parkinson's DiseaseMovement Disorders
Ch4 Density Is a Potential Imaging Biomarker of Cognition in Early Parkinson’s DiseaseAugust 1, 2018Parkinson's DiseaseMovement Disorders
What Is the Prevalence of Sleep Disorders in Neurologic Populations?July 2, 2018Sleep MedicineMovement DisordersEpilepsy & SeizuresNeuro-oncologyStroke
What Are the Best Therapeutic Options for Parkinson’s Disease?June 29, 2018Parkinson's DiseaseMovement Disorders
Experimental Therapy Shows Promise in Early-Stage Huntington’s DiseaseJune 1, 2018Movement DisordersRare Diseases
Tear Proteins May Be Biomarkers for Parkinson’s DiseaseMay 30, 2018Parkinson's DiseaseMovement Disorders
Staging System Classifies Nearly All Patients With Lewy Body SynucleinopathyMay 29, 2018Alzheimer's & CognitionMovement DisordersParkinson's Disease
IncobotulinumtoxinA May Reduce Sialorrhea in Parkinson’s DiseaseMay 29, 2018Parkinson's DiseaseMovement Disorders
Mass Psychogenic Illness: Risk Factors and TreatmentFebruary 5, 2018PediatricsMovement DisordersEpilepsy & Seizures
Virtual House Calls Are Feasible for Patients With Parkinson’s DiseaseNovember 13, 2017Parkinson's DiseaseMovement Disorders
